Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma

Background and objective: Systemic treatments involving immunotherapy-tyrosine kinase inhibitor (IO-TKI) combinations and TKI monotherapy have significantly improved outcomes for patients with metastatic clear-cell renal cell carcinoma (mccRCC). However, there are no biomarkers for predicting the ef...

詳細記述

書誌詳細

主要な著者:	Honglei Cui, Jie Wu, Gan Du, Linjun Hu, Xin Dong, Wang Qu, Hongsong Bai, Bingqing Shang, Ruiyang Xie, Hongzhe Shi, Youyan Guan, Xingang Bi, Changling Li, Jianhui Ma, Aiping Zhou, Jianzhong Shou
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2024-12-01
シリーズ:	European Urology Open Science
主題:	Immunoglobulin G Metastatic clear-cell renal cell carcinoma Prognosis Tyrosine kinase inhibitor Immunotherapy Combination therapy
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2666168324010905
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!